All updates
All updates
today 14EMA News评分3030 EMA News评分2424 Advice on ‘end-of-year’ submission dates for type I variations in 2026
FDA Drugs评分2020 Newly Added Guidance Documents
FDA Drugs评分1717 Generic Drug User Fee Amendments
FDA Drugs评分33 Instructions for Completing Form FDA 3500
FDA Drugs评分1313 Importing Human Drugs
FDA Drugs评分1010 Rare Diseases Team
FDA Drugs评分3737 Public Meeting on the Recommendations for Reauthorization of the Prescription Drug User Fee Act (PDUFA) - 09/16/2026
FDA Drugs评分77 Office of Generic Drugs | Offices and Divisions
FDA Drugs评分2525 C3TI Demonstration Program Frequently Asked Questions (FAQs)
FDA Drugs评分88 What’s New in Clinical Trial Innovation
FDA Drugs评分1010 Clinical Trials Day
FDA Drugs评分1313 CDER Center for Clinical Trial Innovation (C3TI)
FDA Drugs评分99 Facilitating Collaboration Across CDER
FDA Drugs评分33 The CDER Reference Guide
FDA Drugs评分1010 Frequently Asked Questions About Drugs
FDA Drugs评分55 CDERLearn
FDA Drugs评分1818 Drug Interactions | Relevant Regulatory Guidance and Policy Documents
FDA Drugs评分11 Guidance Documents: Office of Drug Information
FDA Drugs评分1010 Regulatory Pharmaceutical Fellowship Program
FDA Drugs评分55 Guidances | Drugs
FDA Drugs评分1010 Generic Drugs
FDA Drugs评分33 Drug Safety Information
FDA Drugs评分66 The Bad Ad Program
FDA Drugs评分2929 How to Request Domperidone for Expanded Access Use
FDA Drugs评分66 Drug Safety-related Labeling Changes (SrLC) Database Overview: Updates to Safety Information in FDA-Approved Prescription Drug Labeling
FDA Drugs评分1313 Over-the-Counter (OTC) | Nonprescription Drugs
FDA Drugs评分1010 FDA Drug Info Rounds Video
FDA Drugs评分1010 Q&A with FDA Podcast
FDA Drugs评分2525 CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
FDA Drugs评分5151 FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
FDA Drugs评分1010 Advancing Generic Drug Development: Translating Science to Approval 2025 - 10/07/2025
FDA Drugs精选评分6363 Fresenius Kabi USA LLC - 733107 - 09/22/2026
FDA Drugs评分2525 Public Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) - 09/17/2026
FDA Drugs评分3232 Biosimilars Action Plan
FDA Drugs评分55 Registered Outsourcing Facilities
FDA Drugs精选评分6161 FDA approves first drug to improve functional capacity and symptoms in children with rare inherited heart condition
FDA Drugs评分1717 Notable Approvals | Drugs
FDA Drugs评分1111 FDA’s Drug Registration and Listing Workshop: Compliance, Regulatory and Submission Updates - 09/29/2026
FDA Drugs评分55 CDER Small Business & Industry Assistance (SBIA)